# Verdict: brenner_tumour.md (re-verification)

1. DOSE LEAK: none. Grepped for digits, mg, AUC, m2, q-day, cycle, day 1, named agents
   (carboplatin/paclitaxel/cisplatin/bevacizumab/olaparib), trial/NCT, and percentages — zero hits
   except "CA125" (a marker name, not a dose) and "12th ed" (citation, not a dose). No specific
   drug names or numeric regimens anywhere in the file; systemic therapy is described only
   generically as "platinum-based chemotherapy."

2. UNGROUNDED / MISLABELLED CLAIMS: none remaining. Every specific management/staging/surgery/
   chemo/monitoring claim in the file carries the "(general oncology standard, not from DeVita's
   section on this disease)" tag. The previously flagged line-13 mis-attribution — the clause
   claiming the malignant-Brenner-equals-other-epithelial-ovarian-cancers equivalence was "the one
   management-adjacent statement present in the reference source material" — has been deleted and
   replaced with the same standard tag used throughout the file. Re-read of current line 13
   confirms no residual wording implies this equivalence is textually present in DeVita.
   Independently re-spot-checked DeVita (grep "brenner", context at lines ~177670-177726 and
   ~177982-177985): DeVita contains only (a) a WHO classification table listing benign /
   borderline / malignant Brenner tumour as histologic tiers with no accompanying treatment text,
   and (b) one sentence listing Brenner tumour among benign solid ovarian masses in the
   adnexal-mass differential — no dedicated management paragraph, confirming the file's grounding
   note is accurate. No fabricated drug names, trial names, or statistics found anywhere in the
   file.

3. CITATION: present at end of file — "Sources: DeVita, Hellman, and Rosenberg's Cancer: Principles
   & Practice of Oncology, 12th ed." Name + edition only, no page numbers. Correct format.

4. VERDICT: CLEAN — ready for R1 re-review.
